Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration

NCT04040205 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT04040205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04040205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Recruiting
Start date
October 7, 2019
Completion date
June 1, 2027
Enrollment
44 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chondrosarcoma, osteosarcoma, soft tissue sarcoma